FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component

48798 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Existential restriction modifier (core metadata concept)
Members targetComponentId
pT1b (IB): Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a2/IA2 (TNM category and FIGO stage) (uterine cervix) pT1b (AJCC)
pT1b (IB): Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a2/IA2 (TNM category and FIGO stage) (uterine cervix) pT1b (AJCC)
pT1b (IB): Tumor confined to the vulva or vulva and perineum, 2 cm or less in greatest dimension, and with stromal invasion greater than 1 mm (TNM category and FIGO stage) (vulva) pT1b (AJCC)
pT1b (IB): Tumor confined to the vulva or vulva and perineum, 2 cm or less in greatest dimension, and with stromal invasion greater than 1 mm (TNM category and FIGO stage) (vulva) pT1b (AJCC)
pT1b (IB): Tumor invades less than one-half of the myometrium (TNM category and FIGO stage) (corpus uteri) pT1b (AJCC)
pT1b (IB): Tumor invades less than one-half of the myometrium (TNM category and FIGO stage) (corpus uteri) pT1b (AJCC)
pT1b (IB): Tumor limited to both ovaries; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) pT1b (AJCC)
pT1b (IB): Tumor limited to both ovaries; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) pT1b (AJCC)
pT1b (IB): Tumor limited to both tubes, without penetrating the serosal surface; no ascites (TNM category and FIGO stage) (fallopian tube) pT1b (AJCC)
pT1b (IB): Tumor limited to both tubes, without penetrating the serosal surface; no ascites (TNM category and FIGO stage) (fallopian tube) pT1b (AJCC)
pT1b category pT1b (AJCC)
pT1b category pT1b (AJCC)
pT1b1 (IB1): Clinically visible lesion 4.0 cm or less in greatest dimension (TNM category and FIGO stage) (uterine cervix) American Joint Committee on Cancer pT1b1 (qualifier value)
pT1b1 (IB1): Clinically visible lesion 4.0 cm or less in greatest dimension (TNM category and FIGO stage) (uterine cervix) American Joint Committee on Cancer pT1b1 (qualifier value)
pT1b1 category American Joint Committee on Cancer pT1b1 (qualifier value)
pT1b1 category American Joint Committee on Cancer pT1b1 (qualifier value)
pT1b2 (IB2): Clinically visible lesion more than 4.0 cm in greatest dimension (TNM category and FIGO stage) (uterine cervix) American Joint Committee on Cancer pT1b2 (qualifier value)
pT1b2 (IB2): Clinically visible lesion more than 4.0 cm in greatest dimension (TNM category and FIGO stage) (uterine cervix) American Joint Committee on Cancer pT1b2 (qualifier value)
pT1b2 category American Joint Committee on Cancer pT1b2 (qualifier value)
pT1b2 category American Joint Committee on Cancer pT1b2 (qualifier value)
pT1b: Melanoma 1.0 mm or less in thickness and level IV or V or with ulceration (melanoma of the skin) pT1b (AJCC)
pT1b: Melanoma 1.0 mm or less in thickness and level IV or V or with ulceration (melanoma of the skin) pT1b (AJCC)
pT1b: Tumor 10 mm or less in greatest diameter and 2.5 mm or less in greatest height (thickness) with microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) pT1b (AJCC)
pT1b: Tumor 10 mm or less in greatest diameter and 2.5 mm or less in greatest height (thickness) with microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) pT1b (AJCC)
pT1b: Tumor 2 cm or less in greatest dimension, limited to dermis and greater than 2 mm in thickness, but not more than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) pT1b (AJCC)
pT1b: Tumor 2 cm or less in greatest dimension, limited to dermis and greater than 2 mm in thickness, but not more than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) pT1b (AJCC)
pT1b: Tumor 5 cm or less in greatest dimension, deep tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) pT1b (AJCC)
pT1b: Tumor 5 cm or less in greatest dimension, deep tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) pT1b (AJCC)
pT1b: Tumor 5 cm or less in greatest dimension, deep tumor (soft tissue) pT1b (AJCC)
pT1b: Tumor 5 cm or less in greatest dimension, deep tumor (soft tissue) pT1b (AJCC)
pT1b: Tumor invades muscle layer (gallbladder) pT1b (AJCC)
pT1b: Tumor invades muscle layer (gallbladder) pT1b (AJCC)
pT1b: Tumor invades submucosa (esophagus) pT1b (AJCC)
pT1b: Tumor invades submucosa (esophagus) pT1b (AJCC)
pT1b: Tumor invades submucosa (stomach) pT1b (AJCC)
pT1b: Tumor invades submucosa (stomach) pT1b (AJCC)
pT1b: Tumor involves both vocal cords (may involve anterior or posterior commissure) with normal mobility (larynx, glottis) pT1b (AJCC)
pT1b: Tumor involves both vocal cords (may involve anterior or posterior commissure) with normal mobility (larynx, glottis) pT1b (AJCC)
pT1b: Tumor involves ipsilateral parietal (mediastinal, diaphragmatic) pleura, with focal involvement of the visceral pleura (thoracic mesothelioma) pT1b (AJCC)
pT1b: Tumor involves ipsilateral parietal (mediastinal, diaphragmatic) pleura, with focal involvement of the visceral pleura (thoracic mesothelioma) pT1b (AJCC)
pT1b: Tumor limited to the iris (more than 3 clock hours in size) (iris) (uveal melanoma) pT1b (AJCC)
pT1b: Tumor limited to the iris (more than 3 clock hours in size) (iris) (uveal melanoma) pT1b (AJCC)
pT1b: Tumor more than 0.5 cm but not more than 1 cm in greatest dimension (breast) pT1b (AJCC)
pT1b: Tumor more than 0.5 cm but not more than 1 cm in greatest dimension (breast) pT1b (AJCC)
pT1b: Tumor more than 4 cm but not more than 7 cm in greatest dimension, limited to the kidney (kidney) pT1b (AJCC)
pT1b: Tumor more than 4 cm but not more than 7 cm in greatest dimension, limited to the kidney (kidney) pT1b (AJCC)
pT1b:Tumor >0.5 cm but <= 1 cm in greatest dimension (breast) pT1b (AJCC)
pT1b:Tumor >0.5 cm but <= 1 cm in greatest dimension (breast) pT1b (AJCC)
pT1c (IC): Tumor invades one-half or more of the myometrium (TNM category and FIGO stage) (corpus uteri) American Joint Committee on Cancer pT1c (qualifier value)
pT1c (IC): Tumor invades one-half or more of the myometrium (TNM category and FIGO stage) (corpus uteri) American Joint Committee on Cancer pT1c (qualifier value)
pT1c (IC): Tumor limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) American Joint Committee on Cancer pT1c (qualifier value)
pT1c (IC): Tumor limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) American Joint Committee on Cancer pT1c (qualifier value)
pT1c (IC): Tumor limited to one or both tubes with extension onto or through the tubal serosa, or with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (fallopian tube) American Joint Committee on Cancer pT1c (qualifier value)
pT1c (IC): Tumor limited to one or both tubes with extension onto or through the tubal serosa, or with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (fallopian tube) American Joint Committee on Cancer pT1c (qualifier value)
pT1c category American Joint Committee on Cancer pT1c (qualifier value)
pT1c category American Joint Committee on Cancer pT1c (qualifier value)
pT1c: Tumor 10 mm or less in greatest diameter and 2.5 mm or less in greatest height (thickness) with macroscopic extraocular extension (ciliary body and choroid) (uveal melanoma) American Joint Committee on Cancer pT1c (qualifier value)
pT1c: Tumor 10 mm or less in greatest diameter and 2.5 mm or less in greatest height (thickness) with macroscopic extraocular extension (ciliary body and choroid) (uveal melanoma) American Joint Committee on Cancer pT1c (qualifier value)
pT1c: Tumor 2 cm or less in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) American Joint Committee on Cancer pT1c (qualifier value)
pT1c: Tumor 2 cm or less in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) American Joint Committee on Cancer pT1c (qualifier value)
pT1c: Tumor limited to the iris with melanomalytic glaucoma (iris) (uveal melanoma) American Joint Committee on Cancer pT1c (qualifier value)
pT1c: Tumor limited to the iris with melanomalytic glaucoma (iris) (uveal melanoma) American Joint Committee on Cancer pT1c (qualifier value)
pT1c: Tumor more than 1 cm but not more than 2 cm in greatest dimension (breast) American Joint Committee on Cancer pT1c (qualifier value)
pT1c: Tumor more than 1 cm but not more than 2 cm in greatest dimension (breast) American Joint Committee on Cancer pT1c (qualifier value)
pT1mic category American Joint Committee on Cancer pT1mi (qualifier value)
pT1mic category American Joint Committee on Cancer pT1mi (qualifier value)
pT1mic: Microinvasion 0.1 cm or less in greatest dimension (breast) American Joint Committee on Cancer pT1mi (qualifier value)
pT1mic: Microinvasion 0.1 cm or less in greatest dimension (breast) American Joint Committee on Cancer pT1mi (qualifier value)
pT2 (II): Cervical carcinoma invades beyond uterus but not to pelvic wall or to lower third of vagina (TNM category and FIGO stage) (uterine cervix) American Joint Committee on Cancer pT2 (qualifier value)
pT2 (II): Cervical carcinoma invades beyond uterus but not to pelvic wall or to lower third of vagina (TNM category and FIGO stage) (uterine cervix) American Joint Committee on Cancer pT2 (qualifier value)
pT2 (II): Tumor confined to the vulva or vulva and perineum, more than 2 cm in greatest dimension (TNM category and FIGO stage) (vulva) American Joint Committee on Cancer pT2 (qualifier value)
pT2 (II): Tumor confined to the vulva or vulva and perineum, more than 2 cm in greatest dimension (TNM category and FIGO stage) (vulva) American Joint Committee on Cancer pT2 (qualifier value)
pT2 (II): Tumor extends outside of uterus but limited to genital structures (ovary, tube, vagina, broad ligaments) (TNM category and FIGO stage) (gestational trophoblast) American Joint Committee on Cancer pT2 (qualifier value)
pT2 (II): Tumor extends outside of uterus but limited to genital structures (ovary, tube, vagina, broad ligaments) (TNM category and FIGO stage) (gestational trophoblast) American Joint Committee on Cancer pT2 (qualifier value)
pT2 (II): Tumor invades cervix but does not extend beyond uterus (TNM category and FIGO stage) (corpus uteri) American Joint Committee on Cancer pT2 (qualifier value)
pT2 (II): Tumor invades cervix but does not extend beyond uterus (TNM category and FIGO stage) (corpus uteri) American Joint Committee on Cancer pT2 (qualifier value)
pT2 (II): Tumor invades paravaginal tissues but not to pelvic wall (TNM category and FIGO stage) (vagina) American Joint Committee on Cancer pT2 (qualifier value)
pT2 (II): Tumor invades paravaginal tissues but not to pelvic wall (TNM category and FIGO stage) (vagina) American Joint Committee on Cancer pT2 (qualifier value)
pT2 (II): Tumor involves one or both fallopian tubes with pelvic extension (TNM category and FIGO stage) (fallopian tube) American Joint Committee on Cancer pT2 (qualifier value)
pT2 (II): Tumor involves one or both fallopian tubes with pelvic extension (TNM category and FIGO stage) (fallopian tube) American Joint Committee on Cancer pT2 (qualifier value)
pT2 (II): Tumor involves one or both ovaries with pelvic extension AND/OR implants (TNM category and FIGO stage) (ovary) American Joint Committee on Cancer pT2 (qualifier value)
pT2 (II): Tumor involves one or both ovaries with pelvic extension AND/OR implants (TNM category and FIGO stage) (ovary) American Joint Committee on Cancer pT2 (qualifier value)
pT2 category American Joint Committee on Cancer pT2 (qualifier value)
pT2 category American Joint Committee on Cancer pT2 (qualifier value)
pT2: Melanoma 1.01 to 2.0 mm in thickness, with or without ulceration (melanoma of the skin) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Melanoma 1.01 to 2.0 mm in thickness, with or without ulceration (melanoma of the skin) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Minimal invasion of the optic nerve and/or optic coats (retinoblastoma) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Minimal invasion of the optic nerve and/or optic coats (retinoblastoma) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Organ confined (prostate) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Organ confined (prostate) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm (liver, including intrahepatic bile ducts) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm (liver, including intrahepatic bile ducts) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates (maxillary sinus) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates (maxillary sinus) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor confluent with or extending into the ciliary body and/or choroid (iris) (uveal melanoma) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor confluent with or extending into the ciliary body and/or choroid (iris) (uveal melanoma) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor extends to the soft tissues (nasopharynx) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor extends to the soft tissues (nasopharynx) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor extends to the supraglottis AND/OR subglottis, AND/OR with impaired vocal cord mobility (larynx, glottis) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor extends to the supraglottis AND/OR subglottis, AND/OR with impaired vocal cord mobility (larynx, glottis) American Joint Committee on Cancer pT2 (qualifier value)
pT2: Tumor extends to vocal cord(s) with normal or impaired mobility (larynx, subglottis) American Joint Committee on Cancer pT2 (qualifier value)

Start Previous Page 483 of 488 Next End

Reference Sets

Reference set descriptor

Back to Start